Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2019

Alidjinou Enagnon Kazali, Coulon Pauline, Hallaert Christophe, Robineau Olivier, Meybeck Agnès, Huleux Thomas, Ajana Faiza, Hober Didier, Bocket Laurence

Abstract excerpt

BACKGROUND: HIV-1 DNA genotypic drug resistance testing is increasingly performed to guide treatment switching or simplification in controlled patients. The Sentosa NGS platform is a fully automated system marketed for drug resistance testing on HIV-1 RNA samples. OBJECTIVES: The aim of this study was to evaluate this automated NGS solution for routine resistance genotypic resistance testing in proviral HIV-1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Proviruses

Share to RNA, Viral

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 31707202
DOI: 10.1016/j.jcv.2019.104207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.PMID 31707202Read ↗

Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.Semantic proximity Read ↗

Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.Semantic proximity Read ↗

A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations.Semantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next-generation sequencing in HIV-positive patients.Semantic proximity Read ↗

RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.Semantic proximity Read ↗

Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.Semantic proximity Read ↗

Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy.Semantic proximity Read ↗

Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.Semantic proximity Read ↗

New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.Semantic proximity Read ↗

Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.